Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze CRVS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CRVS investment potential.

What is CRVS stock price today?

Get real-time CRVS stock price, historical data, and price charts on Financhill. Track CRVS performance with our advanced analysis tools.

Is CRVS a good investment?

Evaluate CRVS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CRVS stock?

To buy CRVS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CRVS?

View detailed market capitalization data and company valuation metrics for CRVS on our comprehensive analysis page.

What is the P/E ratio of CRVS?

Use our fundamental analysis tools to view CRVS P/E ratio and compare valuation metrics with industry peers.

What are CRVS earnings?

View CRVS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Corvus Pharmaceuticals, Inc. Stock Predictions

This AI Layer Just Raised Its Share Price

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

CRVS
Corvus Pharmaceuticals, Inc.

Last Price:

$8.81

Seasonality Move:

-12.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Missed $0.81? RAD Intel Now Open at $0.85/Share

Corvus Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Corvus Pharmaceuticals, Inc. has on average historically risen by 30.8% based on the past 9 years of stock performance.
Corvus Pharmaceuticals, Inc. has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is Corvus Pharmaceuticals, Inc. Stock Undervalued?

The current Corvus Pharmaceuticals, Inc. [CRVS] share price is $8.81. The Score for CRVS is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
CRVS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Corvus Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Corvus Pharmaceuticals, Inc. has on average historically risen by 30.8% based on the past 9 years of stock performance.

Corvus Pharmaceuticals, Inc. Stock Rating

Sell

Corvus Pharmaceuticals, Inc. (CRVS) is a Sell

Is Corvus Pharmaceuticals, Inc. overpriced?

Corvus Pharmaceuticals, Inc. has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Corvus Pharmaceuticals, Inc. Stock Price History

Is CRVS stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

corvuspharma.com

52-Week Data

52-Week High:

9.32

52-Week Low:

2.54

Prediction Charts

Market Cap:

657.9M

Price in USD:

8.81

Volume:

1.2M

Beta:

1.22

Technical Analysis

SMA50:

7.78

SMA100:

6.45

SMA200:

5.14

52-Wk Change:

9.71%

Stock Predictions

Is Corvus Pharmaceuticals, Inc. stock public?

Yes, Corvus Pharmaceuticals, Inc. is a publicly traded company.
What is the Corvus Pharmaceuticals, Inc. stock quote today?

The Corvus Pharmaceuticals, Inc. stock price is 8.81 USD today.
How to buy Corvus Pharmaceuticals, Inc. stock online?

You can buy Corvus Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	7.86	8.77	8.98	7.81
Nov-17	8.82	8.91	9.24	8.72
Nov-18	8.70	9.09	9.15	8.69
Nov-19	9.09	8.90	9.22	8.86
Nov-20	9.10	8.51	9.19	8.47
Nov-21	8.51	8.57	8.80	8.34
Nov-24	8.60	8.58	8.77	8.50
Nov-25	8.56	8.87	8.92	8.49
Nov-26	8.83	9.07	9.32	8.75
Nov-28	9.10	9.17	9.18	8.94
Dec-1	9.17	8.51	9.17	8.31
Dec-2	8.53	8.05	8.57	8.03
Dec-3	8.06	8.44	8.49	8.05
Dec-4	8.44	8.81	8.90	8.40

Corvus Pharmaceuticals, Inc. Earnings

Corvus Pharmaceuticals, Inc. Earnings Report: Per Share Corvus Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Corvus Pharmaceuticals, Inc. Forecast Revenue Growth

Corvus Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Corvus Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.43 per share.

* Corvus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.